openPR Logo
Press release

Companion Diagnostics (CDx) Market size is expected to reach US$ 5.0 Billion by 2024, growing at a CAGR of 12.0% from 2016 to 2024

02-21-2017 01:40 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: MRC Market Research llp

Companion Diagnostics (CDx) Market

Companion Diagnostics (CDx) Market

The global companion diagnostics (CDx) market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period 2016 to 2024

Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.

To Get Sample Copy of Report visit @ https://marketreportscenter.com/request-sample/508244

Market Dynamics:

Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists.

Market Taxonomy:

This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Get the Exemplified Analysis for the Products of Companion diagnostic (CDx) @ https://marketreportscenter.com/reports/508244/companion-diagnostics-market-global-industry-trends-analysis-and-forecast-2017-2024

Key features of the study:

• This report provides in-depth analysis of the companion diagnostics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 to 2024, considering 2015 as the base year

• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

• It profiles leading players in the global companion diagnostics market based on the following parameters company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

• Key companies covered as a part of this study include Abbott Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc. and Siemens Healthcare

• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics

• The global companion diagnostics market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for companion diagnostics, research and consulting firms, new entrants, and financial analysts

• Various strategy matrices used in analyzing the companion diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly.

Ask for Discount @ https://marketreportscenter.com/request-discount/508244

About Us:

Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. Market Reports Center’s team consistently works to update and extend our existing repository of market research reports by partnering with new publishers and adding their studies to our website.

303, Astral Court,

Aundh, Pune,

MH - 411045, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics (CDx) Market size is expected to reach US$ 5.0 Billion by 2024, growing at a CAGR of 12.0% from 2016 to 2024 here

News-ID: 444192 • Views:

More Releases from MRC Market Research llp

Medical 3D Printers Market - Global Industry Analysis, Size, Share, Growth and Forecast Report To 2017
Medical 3D Printers Market - Global Industry Analysis, Size, Share, Growth and F …
MRC announces the addition of new study based research report on Medical 3D Printers Market to their suite of offerings. Where the Medical 3D Printers Market is heading? If you are involved in Medical 3D Printers Market sector, the report brings to your attention a basic overview of the Medical 3D Printers Market with market definition, classification, applications, segmentation, plans, manufacturing processes, product specifications, cost structures, regional analysis, and value chain
Implantable Infusion Pumps Market Size, Share, Analysis, Industry Demand and Forecasts Report to 2017
Implantable Infusion Pumps Market Size, Share, Analysis, Industry Demand and For …
MRC announces the addition of new study based research report on Implantable Infusion Pumps Market to their suite of offerings. Where the Implantable Infusion Pumps Market is heading? If you are involved in Implantable Infusion Pumps Market sector, the report brings to your attention a basic overview of the Implantable Infusion Pumps Market with market definition, classification, applications, segmentation, plans, manufacturing processes, product specifications, cost structures, regional analysis, and value chain
Digital Mobile X-Ray Devices Market - Global Industry Analysis, Size, Share, Growth and Forecast Report To 2017
Digital Mobile X-Ray Devices Market - Global Industry Analysis, Size, Share, Gro …
MRC announces the addition of new study based research report on Digital Mobile X-Ray Devices Market to their suite of offerings. Where the Digital Mobile X-Ray Devices Market is heading? If you are involved in Digital Mobile X-Ray Devices Market sector, the report brings to your attention a basic overview of the Digital Mobile X-Ray Devices Market with market definition, classification, applications, segmentation, plans, manufacturing processes, product specifications, cost structures, regional
Automatic Fare Collection AFC System Market Analysis, Size, Share, Growth and Forecast Report To 2017
Automatic Fare Collection AFC System Market Analysis, Size, Share, Growth and Fo …
Market Reports Center has published a new research-based report on Automatic Fare Collection AFC System Market. This comprehensive report talks about the Automatic Fare Collection AFC System Market in terms of definition, classification, application, forecasts, estimations regarding volume and value. It also features the present scenario and prospects with financial and industrial outlook. Moreover, it includes latest trends, current events, and strategies of leading global companies including key developments, partnerships

All 5 Releases


More Releases for CDx

Global Pharmacogenomics Technology Theranostics CDx Outlook Market Analysis (202 …
LPI (LP Information)' newest research report, the "Pharmacogenomics Technology Theranostics CDx Outlook Industry Forecast" looks at past sales and reviews total world Pharmacogenomics Technology Theranostics CDx Outlook sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmacogenomics Technology Theranostics CDx Outlook sales for 2025 through 2031. With Pharmacogenomics Technology Theranostics CDx Outlook sales broken down by region, market sector and sub-sector, this report provides a
Pharmacogenomics Technology (Theranostics & CDx) market size ascends with a CAGR …
The global Pharmacogenomics Technology (Theranostics & CDx) market size was valued at USD 9869.6 million in 2022 and is forecast to a readjusted size of USD 24800 million by 2029 with a CAGR of 14.1% during review period. The global Pharmacogenomics Technology market has witnessed remarkable growth in recent years, driven by advancements in genetic research, personalized medicine, and the increasing demand for targeted therapies. Pharmacogenomics, the study of how
Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Over …
The Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market report is a perfect foundation for people looking out for a comprehensive study and analysis of the Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market. On the basis of historic growth analysis and current scenario of Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) market place, the report intends to offer actionable insights and outlook on global / regional market growth projections. Authenticated data presented in report is based on findings
Pharmacogenomics Technology Or Theranostics Or Companion Diagnostics (CDx) Marke …
The market study contains demand, application information, price trends, historical and projected market data, company shares of the top Pharmacogenomics Technology Or Theranostics Or Companion Diagnostics (CDx) providers by region. According on application type, geography, and market size (by volume and value), the report segments the market. This report's main goal is to aid the reader in understanding the market in terms of its definition, segmentation, market potential, significant trends,
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Pharmacogenomics Technology
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market survey report has been prepared by conducting market research in a